Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

BNR Udyog Ltd (BNRUDY) Share Price & Fundamentals

Company Overview

Founded Year

1994

Listed Year

-

Headquarter

Hyderabad, India

MD/CEO

Kamal Narayan Rathi

Website

https://bnrul.com/

Company Facts

What we do

BNR Udyog Ltd is a diversified Indian company offering medical transcription, business support services, IT/ITES, financial activities, and recently real estate construction.

Founded in

1,994

Market share

Established player in medical transcription and business support; expanding presence in government e-governance projects and real estate.

Problem solved

Provides accurate medical transcription and billing services improving healthcare documentation; supports government and private sectors with business and IT solutions.

Top clients or who we serve

Major US healthcare providers, Indian government agencies, semi-government, and private enterprises; B2B focus.

Key management

Kamal Narayan Rathi (Managing Director), Sandeep Rathi (Executive Director & CFO).

Our journey and innovations

Started in financial services, diversified into medical transcription in 1999, expanded into medical billing, business support, e-governance, and real estate by 2023.

Where we operate

Primarily India and USA with government projects in Andhra Pradesh and Karnataka and US healthcare clients.

Top products or what we offer

Medical transcription and billing services, business support services, e-governance solutions, and residential real estate development.

Top brands

No specific brand names; flagship services in medical transcription and business support with government e-governance engagements.

Raw materials needed

-

Raw materials supplier

-

Recurring vs cyclical contribution

Service revenues primarily recurring from ongoing contracts in medical transcription and business support.

Our industry position

Mid-sized firm with reputable clientele and government partnerships; building footprint in IT and real estate sectors.

Financial highlights

FY 2024-25 Revenue: Rs. 166.65 Lakhs; Loss: Rs. 54.84 Lakhs; Previous year profit: Rs. 444.57 Lakhs on Rs. 723.72 Lakhs revenue.

Geographical revenue split

Major revenue from India (Rs. 2.19 Cr) and USA (Rs. 1.43 Cr) in services sector.

Order book

-

Whats driving growth

Government e-governance projects, US medical transcription demand, and new real estate construction ventures.

Our future plans

Exploring business expansion in IT/ITES, increase government contracts, and grow real estate development activities.

Our green promise

-

Our people and values

Ten employees with focus on compliance, ethical governance, diversity, and employee welfare.

Key challenges ahead

Financial losses in FY 2024-25, need to scale revenue, market competition, and diversification risks.

Interesting facts

Employee remuneration ratio to median is around 8-9 times for top executives; zero complaints in workplace policies.

Risks and strategy

Focus on risk management, compliance, leveraging government projects, and diversifying into real estate to mitigate revenue volatility.

Market Footprint

Top Clients

Top Clients

Major US healthcare providers, Indian government agencies, semi-government, and private enterprises; B2B focus.

Top Products

Top Products

Medical transcription and billing services, business support services, e-governance solutions, and residential real estate development.

Price Movement & Share Holding

Today's High/Low

3135

52 Week High/Low

2849
Past Returns

1 week

-11.81%

1 month

-14.58%

3 month

-5.09%

1 year

-31.34%

3 year

-25.42%

5 year

95.58%

Share Holding

Promoters

71.59%

FII

0%

DII

0%

Retail

23.35%

Others

5.06%

Company Overview

Founded Year

1994

Listed Year

-

Headquarter

Hyderabad, India

MD/CEO

Kamal Narayan Rathi (Managing Director)

Website

https://bnrul.com/

Price Movement & Share Holding

Today's High/Low

3135

52 Week High/Low

2849

Past Returns

1 week

-11.81%

1 month

-14.58%

3 month

-5.09%

1 year

-31.34%

3 year

-25.42%

5 year

95.58%

Share Holding

Promoters

71.59%

FII

0%

DII

0%

Retail

23.35%

Others

5.06%

Company Facts

What we do

BNR Udyog Ltd is a diversified Indian company offering medical transcription, business support services, IT/ITES, financial activities, and recently real estate construction.

Founded in

1994

Market share

Established player in medical transcription and business support; expanding presence in government e-governance projects and real estate.

Problem solved

Provides accurate medical transcription and billing services improving healthcare documentation; supports government and private sectors with business and IT solutions.

Top clients or who we serve

Major US healthcare providers, Indian government agencies, semi-government, and private enterprises; B2B focus.

Key management

Kamal Narayan Rathi (Managing Director), Sandeep Rathi (Executive Director & CFO).

Our journey and innovations

Started in financial services, diversified into medical transcription in 1999, expanded into medical billing, business support, e-governance, and real estate by 2023.

Where we operate

Primarily India and USA with government projects in Andhra Pradesh and Karnataka and US healthcare clients.

Top products or what we offer

Medical transcription and billing services, business support services, e-governance solutions, and residential real estate development.

Top brands

No specific brand names; flagship services in medical transcription and business support with government e-governance engagements.

Recurring vs cyclical contribution

Service revenues primarily recurring from ongoing contracts in medical transcription and business support.

Our industry position

Mid-sized firm with reputable clientele and government partnerships; building footprint in IT and real estate sectors.

Financial highlights

FY 2024-25 Revenue: Rs. 166.65 Lakhs; Loss: Rs. 54.84 Lakhs; Previous year profit: Rs. 444.57 Lakhs on Rs. 723.72 Lakhs revenue.

Geographical revenue split

Major revenue from India (Rs. 2.19 Cr) and USA (Rs. 1.43 Cr) in services sector.

Whats driving growth

Government e-governance projects, US medical transcription demand, and new real estate construction ventures.

Our future plans

Exploring business expansion in IT/ITES, increase government contracts, and grow real estate development activities.

Our people and values

Ten employees with focus on compliance, ethical governance, diversity, and employee welfare.

Key challenges ahead

Financial losses in FY 2024-25, need to scale revenue, market competition, and diversification risks.

Interesting facts

Employee remuneration ratio to median is around 8-9 times for top executives; zero complaints in workplace policies.

Risks and strategy

Focus on risk management, compliance, leveraging government projects, and diversifying into real estate to mitigate revenue volatility.

Market Footprint

Top Clients

Top Clients

Major US healthcare providers, Indian government agencies, semi-government, and private enterprises; B2B focus.

Top Products

Top Products

Medical transcription and billing services, business support services, e-governance solutions, and residential real estate development.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions